Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast

American Journal of Roentgenology

Volumn 179, Issue 6, 2002, Pages 1485-1492

  Kelcz, Frederick ^a   Furman Haran, Edna ^b   Grobgeld, Dov ^b   Degani, Hadassa ^b  

^a University of Wisconsin Health   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; BREAST DISEASE; BREAST FIBROADENOMA; BREAST TUMOR; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMAGE QUALITY; INFUSION PUMP; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0036893135     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.6.1791485     Document Type: Article

References (29)

1. Kaiser WA, Zeitler E. MR Imaging of the breast: Fast imaging sequences with and without GdDTPA: Preliminary observations. Radiology 1989;170:681-686
2. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-494
3. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-631
4. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with gadolinium-enhanced turboFLASH subtraction technique. Radiology 1994;193:777-781
5. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 1994;187:493-501
6. Kelcz F, Santyr GE, Cron GO. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic. Gd-enhanced MRI. J Magn Resort Imaging 1996;6:743-752
7. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: Experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842
8. Leong CS, Daniel BL, Herfkens RJ, et al. Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI. J Magn Resort Imaging 2000;11:87-96
9. Daniel BL, Yen YF, Glover GH, et al. Breast disease: Dynamic spiral MR imaging. Radiology 1998; 209:499-509
10. Orel SG, Mednonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR Imaging of ductal carcinoma in situ. Radiology 1997;202:413-420
11. Orel GS, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994;190:485-493
12. Muller-Schimpfle M, Ohmenhauser K, Sand J, Stoll P, Claussen CD. Dynamic 3D-MR mammography: Is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Imaging 1997;7:236-240
13. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110
14. Orel SG. MR imaging of the breast. Radiol Clin North Am 2000;38:899-913
15. Degani H, Gusis V, Weinstein D, et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997;3:780-782
16. Furman-Haran E, Grobgeld, Margalit R, Degani H. Response of MCF7 human breast cancer to tamoxifen: Evaluation by the three time point (3TP), contrast enhanced MRI method. Clin Cancer Res 1998;4:2299-2304
17. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR Imaging. 1. Fundamental concepts. Magn Resort Med 1991;17:357-367
18. Furman-Haran E, Grobgeld D, Kelcz F, Degani H. Critical role of spatial resolution in dynamic contrast-enhanced breast MRI. J Magn Reson Imaging 2001;13:862-867
19. Larson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131
20. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNX Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-4328
21. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: Diagnostic criteria and interobserver variability. AJR 2000;175:35-43
22. Sherif H, Mahfouz AE, Oellinger H, et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997;205:209-213
23. Weinmann HJ, Laniado M, Mutzel W, Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Meal NMR 1984;16:167-172
24. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS), 3rd Ed. Reston, VA: American College of Radiology, 1998
25. Piccoli CW. Contrast-enhanced breast MRI: Factors affecting sensitivity and specificity. Eur Radiol 1997;7(suppl 5):281-288
26. Kuhl CK. MRI of breast tumors. Eur Radiol 2000;10:46-58
27. Lucht R, Knopp MV, Brix G. Elastic matching of dynamic MR mammographic images. Magn Reson Med 2000;43:9-16
28. Hayton P, Brady M, Tarassenko L, Moore N. Analysis of dynamic MR breast images using a model of contrast enhancement. Med Image Anal 1997;1:207-224
29. Boetes C, Strijk SP, Holland R, Barentsz JO, Van Der Sluis RF, Ruijs JH. False-negative MR imaging of malignant breast tumors. Eur Radiol 1997;7:1231-1234